The practice was then progressively extended until the end of the first half-year, inline with the first emergency period which ended on 10 July 2020. In the period from April to June 2020, the Group thus settled nearly €500 million of invoices before the contractual deadline for very small, small and medium-sized suppliers in France.These measures taken in the first half-year have no impact on the Group’s working capital at 31 December 2020.
In accordance with AMF and ANC recommendations, the Group has not applied any different classifications as a result of Covid-19 from those normally used in its income statement. In-depth analyses were conducted in the Group’s local entities and centrally for the half-year closing at 30 June 2020, then the annual closing at 31 December 2020, to prepare reliable estimates of the impacts of the pandemic on the Group’s financial statements. The main estimated impacts of the Covid-19 pandemic on items of the Group’s income statement are presented below.
The pandemic’s impact on sales at 31 December 2020 is an estimated €(2,306) million (or around -3.3% of total sales). This impact mainly concerns the following business segments:
The impact of the Covid-19 pandemic on fuel and energy purchases at 31 December 2020, due to the decline it caused in nuclear power output and demand for electricity and gas, is an estimated decrease of approximately €854 million, principally in the France – Regulated activities and France – Generation and Supply segments and the United Kingdom.
The pandemic also had an estimated downward impact of €344 million on external expenses (net of capitalised production costs) reflecting several types of effect:
Personnel expenses increased by some €64 million, principally in connection with the business recovery plan introduced by the Group. This amount includes indemnities received or receivable under furlough schemes in some Group entities inFrance (see note 1.4.1.5), amounting to approximately €18 million, together with the unfavourable effects of the pandemic in terms of employee holiday pay at certain Group entities in France.
Finally, other operating income and expenses were adversely affected to the extent of some €(309) million, including €(204) million following revaluation of impairment of trade receivables in various Group entities (see note 1.4.1.2) and €(45) million due to an increase in decommissioning provisions for permanently shut-down nuclear power plants in France where decommissioning work had to be postponed.
The above estimated impacts were prepared from specific reporting set up by the Management with all Group entities as part of the closing for the consolidated financial statements, applying the following approaches:
The resulting estimated impact of the Covid-19 pandemic on Operating profit before depreciation and amortisation at 31 December 2020 is some €(1,479) million (at 30 June it was some € (1,010) million). This impact mainly concerns the following business segments: France - Generation and Supply (€ (872) million against € (482) million in the first half-year), France - Regulated activities (€(237) million against €(212) million in the first half-year) and the United Kingdom (€ (182) million against €(128) million in the first half-year). The pandemic’s estimated impacts on the Group’s other business segments are less material given the consolidated operating profit before depreciation and amortisation at that date, and mainly concern Dalkia (€(40) million against € (39) million in the first half-year), Framatome (€(47) million against €(37) million in the first half-year), and Italy (Edison) (€(60) million against€(47) million in the first half-year).
Some estimates reflecting the information known to the Group at 31 December 2020, notably concerning the risk of non-recovery of customer receivables, are uncertain by nature. The final situation would differ from the year-end estimates, depending on how the crisis ends, and more broadly the economic consequences in 2021.
Finally, it should be noted that the financial result has been significantly impacted by the decline on the financial markets, through changes in the fair value of financial instruments in the first half-year (see note 12 to the condensed consolidated half-year financial statements). The behaviour of the financial markets in the second half-year, combined with the Group’s allocation approach for portfolio management, led to clearly positive changes in the fair value of financial instruments at 31 December 2020 (see note 8).
The Group has also recognised impairment in 2020 that among other factors reflect indirect effects of the pandemic (see note 10.8).